Early and rapid detection of UCHL1 in the serum of brain-trauma patients: a novel gold nanoparticle-based method for diagnosing the severity of brain injury. Issue 14 (12th June 2018)

• Record Type: Journal Article
• Authors: Singh, Gyaninder Pal; Nigam, Richa; Tomar, Gaurav Singh; Monisha, Mohan; Bhoi, Sanjeev Kumar; S, Arulselvi; Sengar, Kangana; Akula, Deepa; Panta, Prashanth; Anindya, Roy
• Is Part Of: Analyst. Volume 143:Issue 14(2018)
• Page Start: 3366
• Page End: 3373
• Publication Date: 2018-06-12
• Subjects: Chemistry, Analytic -- Periodicals; 543
• DOI: 10.1039/c8an00533h
• Languages: English
• ISSNs: 0003-2654

Abstract

Abstract : We provide a gold nanoparticle-based method for traumatic brain injury diagnosis. Abstract : The clinical diagnosis of traumatic brain injury (TBI) is based on neurological examination and neuro-imaging tools such as CT scanning and MRI. However, neurological examination at times may be confounded by consumption of alcohol or drugs and neuroimaging facilities may not be available at all centers. Human ubiquitin C-terminal hydrolase (UCHL1) is a well-accepted serum biomarker for severe TBI and can be used to detect the severity of a head injury. A reliable, rapid, cost effective, bedside and easy to perform method for the detection of UCHL1 is a pre-requisite for wide clinical applications of UCHL1 as a TBI biomarker. We developed a rapid detection method for UCHL1 using surface plasmon resonance of gold nanoparticles with a limit of detection (LOD) of 0.5 ng mL −1 . It has a sensitivity and specificity of 100% each and meets an analytical precision similar to that of conventional sandwich ELISA but can be performed rapidly. Using this method we successfully detected UCHL1 in a cohort of 66 patients with TBI and were reliably able to distinguish mild TBI from moderate to severe TBI.